2021 Annual Meeting | S17 - History of Neurology
Program Materials Program Evaluations
| 04:00 PM - 04:08 PM EDT | Abstract |
001 - Historical Perspectives of Thrombolysis in Acute Ischemic Stroke Before the Alteplase Era
Jorge G. Ortiz-Garcia, MD, FAAN |
| 04:08 PM - 04:16 PM EDT | Abstract |
002 - Powdered Human Skulls in New Spain: Epilepsy Care before Pedro de Horta, the First American Epileptologist
Guillermo R. Delgado-Garcia, MD, MSc |
| 04:16 PM - 04:24 PM EDT | Q&A |
Questions and Answers
|
| 04:24 PM - 04:32 PM EDT | Abstract |
003 - The Color of Neurology Workforce
Aminah Abdul Razzack |
| 04:32 PM - 04:40 PM EDT | Abstract |
004 - Disentangling the Gordian Knot: The birth, father, and future of balloon embolization
Victor Ekuta, MD |
| 04:40 PM - 04:48 PM EDT | Abstract |
005 - Dr. Betty G. Clements: Breaking Gender Barriers in the Air Force and Neurology
Elizabeth A. Coon, MD, FAAN |
| 04:48 PM - 05:00 PM EDT | Q&A |
Questions and Answers
|
| No disclosure on file | |
| Ronald Alvarado Dyer, MD | Dr. Alvarado Dyer has nothing to disclose. |
| Faddi G. Saleh Velez, MD | Dr. Saleh Velez has nothing to disclose. |
| Guillermo R. Delgado-Garcia, MD, MSc | Dr. Delgado-Garcia has received research support from Consejo Nacional de Ciencia y Tecnologia (Mexico). Dr. Delgado-Garcia has received research support from Consejo Nacional de Ciencia y Tecnologia (Mexico). Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Team Member with Neurology Resident & Fellow Section that is relevant to AAN interests or activities. Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Board Member with Brain and Life en Espanol that is relevant to AAN interests or activities. Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Board Member with Neurology Clinical Practice that is relevant to AAN interests or activities. |
| Elizabeth A. Coon, MD, FAAN | Dr. Coon has nothing to disclose. |
| Jorge G. Ortiz-Garcia, MD, FAAN | Dr. Ortiz-Garcia has nothing to disclose. |
| Bruno E. Vidal, MD | No disclosure on file |
| Victor Ekuta, MD | Dr. Ekuta has stock in Doximity. Dr. Ekuta has received research support from Rainwater Charitable Foundation. Dr. Ekuta has received research support from Cell Press, Elsevier, Cell Signaling Technologies. Dr. Ekuta has received research support from Rare Disease Diversity Coalition. |
| Aminah Abdul Razzack | Ms. Abdul Razzack has nothing to disclose. |
| Christopher J. Boes, MD, FAAN | Dr. Boes has nothing to disclose. |
| Stefano Sandrone, PhD | Dr. Sandrone has nothing to disclose. |
| Eric S. Farbman, MD, FAAN | Dr. Farbman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Farbman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Farbman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. |